In estrogen receptor-positive breast cancer cells that overexpressed aromatase (MCF-7aro), CBD (up to 20 μM) greatly suppressed cell growth by disrupting cell cycle progression and inducing autophagy to promote apoptosis, accompanied by inhibited aromatase activity and estrogen receptor α expression and enhanced estrogen receptor β expression [36]. Here, CYP19A1 is linked to breast cancer.